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B E L L W E T H E R  5 7 7
Judith Rodin, CW’66, president of the Uni-
versity of Pennsylvania since 1994, announced
on June 20, 2003, that she intends to step down
from the office
when she com-
pletes her 10-year
term in June 2004.
Rodin became
Penn’s president
on July 1, 1994,
coming to Penn
from Yale, where
she had been
Provost. She was
the first woman to be named to the presidency
of an Ivy League institution, and the first Penn
alumna to serve as president.
During nearly a decade of service, Rodin
has guided the University through a period of
unprecedented growth and development that
has transformed Penn’s academic core and dra-
matically enhanced the quality of life on cam-
pus and in the surrounding community. Under
her leadership, Penn has invigorated its
resources, doubling its research funding and
tripling both its annual fundraising and the
size of its endowment; created Penn Medicine;
launched a comprehensive and widely
acclaimed neighborhood revitalization pro-
gram; attracted record numbers of undergrad-
uate applicants, creating Penn’s most selective
classes ever; risen in the U.S News & World
Report rankings of top national research uni-
versities from 16th in 1994 to 4th in 2002;
established new interdisciplinary institutes and
created over a dozen groundbreaking interdis-
ciplinary, multi-school, undergraduate, and
graduate degree programs throughout the Uni-
versity; planned or completed new buildings
and major renovations in every school and
center; and expanded its international pro-
grams and collaborations. Faculty excellence
has risen dramatically and there has been sig-
nificant investment in leading-edge graduate
and professional degree programs.
“Serving Penn these past years has been an
extraordinary privilege and an exhilarating
experience,” Rodin said. “This is a remarkable
community of amazing depth and breadth, and
I am grateful to the Trustees for their support
and for giving me the opportunity to work
with so many talented and creative individuals.
I am very proud of all that our faculty, staff,
students, alumni and community partners have
together enabled Penn to accomplish.
“The decision to step down has been an
extremely difficult one for me to make, but I
believe it is the right time for Penn. We have
successfully fulfilled our first strategic plan and
with the next plan conceived and ready to
launch, it is time for the next era of leadership.
I love this institution and will always remain a
part of it.”
The executive committee of Penn’s Board of
Trustees will appoint in the months ahead a
presidential search committee, to be comprised
of trustees, faculty, and students, which will be
chaired by James S. Riepe, W’65 WG’67, the
Board chairman. For more information, visit
the “Judith Rodin: An Enduring Legacy”
website at <www.upenn.edu/pennnews/
rodin_legacy/>.
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Researchers at the School have created the
first mammalian gametes grown in vitro
directly from embryonic stem cells. The work,
in which mouse stem cells placed in Petri
dishes—without any special growth or tran-
scription factors—grew into oocytes and then
into embryos, was reported in early May on the
website of the journal Science.
The results demonstrate that even outside
the body embryonic stem cells remain totipo-
tent, or capable of generating any of the body’s
tissues, said lead researcher Dr. Hans R.
Schöler, professor of reproduction medicine
and director of Penn’s Center for Animal
Transgenesis and Germ Cell Research.
“Most scientists have thought it impossible
to grow gametes from stem cells outside the
body, since earlier efforts have yielded only
somatic cells,” said Schöler. “We found that not
only can mouse embryonic stem cells produce
oocytes, but that these oocytes can then enter
meiosis, recruit adjacent cells to form struc-
tures similar to the follicles that surround and
nurture natural mouse eggs, and develop into
embryos.”
Schöler said oocyte development in vitro
may offer a new way for embryonic stem cells
to be produced artificially, sidestepping the
ethical concerns articulated by President Bush
and others. Implanting a regular nucleus from
any of the body’s cells into such an oocyte
would yield a totipotent stem cell.
The findings may force legal revisions in
nations such as Germany whose lawmakers,
assuming that stem cells’ potency outside the
body was limited, have passed legislation ban-
ning research with totipotent stem cells.
The Penn scientists pulled off this feat using
a gene called Oct4 as a genetic marker. After
the stem cells were plated in a regular Petri
dish—densely but without special feeder cells
or growth factors—the scientists used fluores-
cent markers linked to Oct4 and other telltale
genes to assay oocyte development. After 12
days in culture, the cells organized into
colonies of variable size. Shortly thereafter,
individual cells detached from these colonies.
“These germ cells then accumulated a coat-
ing of cells similar to the follicles surrounding
mammalian eggs,” Schöler said. “Starting on
day 26, oocyte-like cells were released into the
culture—similar to ovulation—and by day 43,
embryo-like structures arose through
parthenogenesis, or spontaneous reproduction
without sperm.”
In the experiment described in Science, both
male- and female-derived stem cells developed
into female gametes. Schöler and colleagues
now plan to test whether oocytes developed in
vitro can be fertilized.
“We would like to use these oocytes as a
basis for therapeutic cloning, and hope that
our results can be replicated with human
embryonic stem cells,” Schöler said.
Schöler was joined in the research by Karin
Hübner, James Kehler, Rolland Reinbold,
Rabindranath de la Fuente, and Michele Boiani
of Penn’s School of Veterinary Medicine; Lane
K. Christenson, Jennifer Wood, and Jerome
Strauss III from Penn’s School of Medicine;
and Guy Fuhrmann of the Centre de Neuro-
chimie in France. The work was funded by the
National Institutes of Health, the Marion Dilley
and David George Jones Funds, the Common-
wealth and General Assembly of Pennsylvania,
and the Association pour la Recherche sur la
Cancer.
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